Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Felix B who wrote (3278)	4/13/2021 9:47:33 AM
From: CuttingEdge Bio	Read Replies (1) \| Respond to of 3557

As it has been since the beginning, the timing doesn't seem to align right for this treatment unfortunately. IMO, they should surge supply to countries that are struggling to get vaccination supply online and failing to rollout vaccination and are having outbreaks and renewing lockdowns etc. But again, timing. So much red tape. And then price negotiations, etc. This is a treatment that works, but it looks like over 2/3's of Americans will be vaccinated, and even higher numbers of older demographics, so how does it have a use? At this point, I don't see it. Maybe I'm wrong.